Distinct Modes of Cyclin E/Cdc2c Kinase Regulation and S-Phase Control in Mitotic and Endoreduplication Cycles of Drosophila Embryogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Plasticity in Ploidy: a Generalized Response to Stress
Review Plasticity in ploidy: a generalized response to stress Daniel R. Scholes and Ken N. Paige School of Integrative Biology, University of Illinois at Urbana-Champaign, 515 Morrill Hall, 505 South Goodwin Avenue, Urbana, IL 61801, USA Endoreduplication, the replication of the genome with- or greater) are a general feature of endosperm and sus- out mitosis, leads to an increase in the cellular ploidy of pensor cells of seed across endopolyploid taxa [9]. Very low an organism over its lifetime, a condition termed ‘endo- (or the complete lack of) endopolyploidy across taxa is polyploidy’. Endopolyploidy is thought to play signifi- observed in a few cell types, including phloem companion cant roles in physiology and development through cells and stomatal guard cells, both of which serve highly cellular, metabolic, and genetic effects. While the occur- specialized functions that would possibly be disrupted by rence of endopolyploidy has been observed widely increased ploidy [7,9]. Because endoreduplication is a across taxa, studies have only recently begun to charac- somatic process, the embryo and meristematic cells terize and manipulate endopolyploidy with a focus on its (e.g., procambium, root and shoot apical meristems) also ecological and evolutionary importance. No compilation lack endopolyploidy [6,7,9]. Finally, mixed ploidy among of these examples implicating endoreduplication as a adjacent cells of the same type also occurs (e.g., leaf generalized response to stress has thus far been made, epidermal pavement cells range from 2C to 64C) [7,9]. despite the growing evidence supporting this notion. Although generalized patterns of endopolyploidy may We review here the recent literature of stress-induced be observed within and among plants, recent evidence endopolyploidy and suggest that plants employ endor- suggests that many plants that endoreduplicate can plas- eduplication as an adaptive, plastic response to mitigate tically increase their endopolyploidy beyond their ‘normal’ the effects of stress. -
Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its
Published OnlineFirst January 21, 2015; DOI: 10.1158/1078-0432.CCR-14-1950 Biology of Human Tumors Clinical Cancer Research Cyclin-Dependent Kinase 5 Decreases in Gastric Cancer and Its Nuclear Accumulation Suppresses Gastric Tumorigenesis Longlong Cao1,2, Jiechao Zhou2, Junrong Zhang1,2, Sijin Wu3, Xintao Yang1,2, Xin Zhao2, Huifang Li2, Ming Luo1, Qian Yu1, Guangtan Lin1, Huizhong Lin1, Jianwei Xie1, Ping Li1, Xiaoqing Hu3, Chaohui Zheng1, Guojun Bu2, Yun-wu Zhang2,4, Huaxi Xu2,4,5, Yongliang Yang3, Changming Huang1, and Jie Zhang2,4 Abstract Purpose: As a cyclin-independent atypical CDK, the role of correlated with the severity of gastric cancer based on tumor CDK5 in regulating cell proliferation in gastric cancer remains and lymph node metastasis and patient 5-year fatality rate. unknown. Nuclear localization of CDK5 was found to be significantly Experimental Design: Expression of CDK5 in gastric tumor decreased in tumor tissues and gastric cancer cell lines, and paired adjacent noncancerous tissues from 437 patients was whereas exogenously expression of nucleus-targeted CDK5 measured by Western blotting, immunohistochemistry, and real- inhibited the proliferation and xenograft implantation of time PCR. The subcellular translocation of CDK5 was monitored gastric cancer cells. Treatment with the small molecule during gastric cancer cell proliferation. The role of nuclear CDK5 NS-0011, which increases CDK5 accumulation in the nucleus, in gastric cancer tumorigenic proliferation and ex vivo xenografts suppressed both cancer cell proliferation and xenograft was explored. Furthermore, by screening for compounds in the tumorigenesis. PubChem database that disrupt CDK5 association with its nu- Conclusions: Our results suggest that low CDK5 expression is clear export facilitator, we identified a small molecular (NS-0011) associated with poor overall survival in patients with gastric that inhibits gastric cancer cell growth. -
The Cryoelectron Microscopy Structure of the Human CDK-Activating Kinase
The cryoelectron microscopy structure of the human CDK-activating kinase Basil J. Grebera,b,1,2, Juan M. Perez-Bertoldic, Kif Limd, Anthony T. Iavaronee, Daniel B. Tosoa, and Eva Nogalesa,b,d,f,2 aCalifornia Institute for Quantitative Biosciences (QB3), University of California, Berkeley, CA 94720; bMolecular Biophysics and Integrative Bio-Imaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; cBiophysics Graduate Group, University of California, Berkeley, CA 94720; dDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; eQB3/Chemistry Mass Spectrometry Facility, University of California, Berkeley, CA 94720; and fHoward Hughes Medical Institute, University of California, Berkeley, CA 94720 Edited by Seth A. Darst, Rockefeller University, New York, NY, and approved August 4, 2020 (received for review May 14, 2020) The human CDK-activating kinase (CAK), a complex composed of phosphoryl transfer (11). However, in addition to cyclin binding, cyclin-dependent kinase (CDK) 7, cyclin H, and MAT1, is a critical full activation of cell cycle CDKs requires phosphorylation of the regulator of transcription initiation and the cell cycle. It acts by T-loop (9, 12). In animal cells, these activating phosphorylations phosphorylating the C-terminal heptapeptide repeat domain of are carried out by CDK7 (13, 14), itself a cyclin-dependent ki- the RNA polymerase II (Pol II) subunit RPB1, which is an important nase whose activity depends on cyclin H (14). regulatory event in transcription initiation by Pol II, and it phos- In human and other metazoan cells, regulation of transcription phorylates the regulatory T-loop of CDKs that control cell cycle initiation by phosphorylation of the Pol II-CTD and phosphor- progression. -
Cell Cycle Arrest and DNA Endoreduplication Following P21waf1/Cip1 Expression
Oncogene (1998) 17, 1691 ± 1703 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression Stewart Bates, Kevin M Ryan, Andrew C Phillips and Karen H Vousden ABL Basic Research Program, NCI-FCRDC, Building 560, Room 22-96, West 7th Street, Frederick, Maryland 21702-1201, USA p21Waf1/Cip1 is a major transcriptional target of p53 and there are an increasing number of regulatory mechan- has been shown to be one of the principal mediators of isms that serve to inhibit cdk activity. Primary amongst the p53 induced G1 cell cycle arrest. We show that in these is the expression of cdk inhibitors (CDKIs) that addition to the G1 block, p21Waf1/Cip1 can also contribute can bind to and inhibit cyclin/cdk complexes (Sherr to a delay in G2 and expression of p21Waf1/Cip1 gives rise and Roberts, 1996). These fall into two classes, the to cell cycle pro®les essentially indistinguishable from INK family which bind to cdk4 and cdk6 and inhibit those obtained following p53 expression. Arrest of cells complex formation with D-cyclins, and the p21Waf1/Cip1 in G2 likely re¯ects an inability to induce cyclin B1/cdc2 family that bind to cyclin/cdk complexes and inhibit kinase activity in the presence of p21Waf1/Cip1, although the kinase activity. inecient association of p21Waf1/Cip1 and cyclin B1 The p21Waf1/Cip1 family of CDKIs include p21Waf1/Cip1, suggests that the mechanism of inhibition is indirect. p27 and p57 and are broad range inhibitors of cyclin/ Cells released from an S-phase block were not retarded cdk complexes (Gu et al., 1993; Harper et al., 1993; in their ability to progress through S-phase by the Xiong et al., 1993; Firpo et al., 1994; Polyak et al., presence of p21Waf1/Cip1, despite ecient inhibition of 1994; Toyoshima and Hunter, 1994; Lee et al., 1995; cyclin E, A and B1 dependent kinase activity, suggesting Matsuoka et al., 1995). -
Cyclin-Dependent Kinase Inhibitors KRP1 and KRP2 Are Involved in Grain Filling and Seed Germination in Rice (Oryza Sativa L.)
International Journal of Molecular Sciences Article Cyclin-Dependent Kinase Inhibitors KRP1 and KRP2 Are Involved in Grain Filling and Seed Germination in Rice (Oryza sativa L.) Abolore Adijat Ajadi 1,2, Xiaohong Tong 1, Huimei Wang 1, Juan Zhao 1, Liqun Tang 1, Zhiyong Li 1, Xixi Liu 1, Yazhou Shu 1, Shufan Li 1, Shuang Wang 1,3, Wanning Liu 1, Sani Muhammad Tajo 1, Jian Zhang 1,* and Yifeng Wang 1,* 1 State Key Lab of Rice Biology, China National Rice Research Institute, Hangzhou 311400, China; [email protected] (A.A.A.); [email protected] (X.T.); [email protected] (H.W.); [email protected] (J.Z.); [email protected] (L.T.); [email protected] (Z.L.); [email protected] (X.L.); [email protected] (Y.S.); [email protected] (S.L.); [email protected] (S.W.); [email protected] (W.L.); [email protected] (S.M.T.) 2 Biotechnology Unit, National Cereals Research Institute, Badeggi, Bida 912101, Nigeria 3 College of Life Science, Yangtze University, Jingzhou 434025, China * Correspondence: [email protected] (J.Z.); [email protected] (Y.W.); Tel./Fax: +86-571-6337-0277 (J.Z.); +86-571-6337-0206 (Y.W.) Received: 21 November 2019; Accepted: 26 December 2019; Published: 30 December 2019 Abstract: Cyclin-dependent kinase inhibitors known as KRPs (kip-related proteins) control the progression of plant cell cycles and modulate various plant developmental processes. However, the function of KRPs in rice remains largely unknown. In this study, two rice KRPs members, KRP1 and KRP2, were found to be predominantly expressed in developing seeds and were significantly induced by exogenous abscisic acid (ABA) and Brassinosteroid (BR) applications. -
Involvement in Endoreduplication (Cell Cycle/Repa/Wheat Dwarf Virus) GIDEON GRAFI*T#, RONALD J
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 8962-8967, August 1996 Cell Biology A maize cDNA encoding a member of the retinoblastoma protein family: Involvement in endoreduplication (cell cycle/RepA/wheat dwarf virus) GIDEON GRAFI*t#, RONALD J. BURNETTr*, TIM HELENTJARIS*, BRIAN A. LARKINS*§, JAMES A. DECAPRIOt, WILLIAM R. SELLERSt, AND WILLIAM G. KAELIN, JR.t *Department of Plant Sciences, University of Arizona, Tucson AZ 85721; and tDana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115 Contributed by Brian A. Larkins, May 14, 1996 ABSTRACT Retinoblastoma (RB-1) is a tumor suppres- We identified a partial maize cDNA (ZmRB) that is pre- sor gene that encodes a 105-kDa nuclear phosphoprotein. To dicted to encode a protein with homology to members of the date, RB genes have been isolated only from metazoans. We pocket protein (Rb) family. Here we provide evidence that have isolated a cDNA from maize endosperm whose predicted ZmRb is a member of the retinoblastoma protein family and protein product (ZmRb) shows homology to the "pocket" A demonstrate its ability to bind the replication-associated pro- and B domains of the Rb protein family. We found ZmRb tein WDV RepA and its involvement in the process of DNA behaves as a pocket protein based on its ability to specifically endoreduplication during maize endosperm development. interact with oncoproteins encoded by DNA tumor viruses (E7, T-Ag, E1A). ZmRb can interact in vitro and in vivo with MATERIALS AND METHODS the replication-associated protein, RepA, encoded by the wheat dwarf virus. The maize Rb-related protein undergoes Plant Materials and Chemicals. -
The P16 Status of Tumor Cell Lines Identifies Small Molecule Inhibitors Specific for Cyclin-Dependent Kinase 41
Vol. 5, 4279–4286, December 1999 Clinical Cancer Research 4279 The p16 Status of Tumor Cell Lines Identifies Small Molecule Inhibitors Specific for Cyclin-dependent Kinase 41 Akihito Kubo,2 Kazuhiko Nakagawa,2, 3 CDK4 kinase inhibitors that may selectively induce growth Ravi K. Varma, Nicholas K. Conrad, inhibition of p16-altered tumors. Jin Quan Cheng, Wen-Ching Lee, INTRODUCTION Joseph R. Testa, Bruce E. Johnson, INK4A 4 The p16 gene (also known as CDKN2A) encodes p16 , Frederic J. Kaye, and Michael J. Kelley which inhibits the CDK45:cyclin D and CDK6:cyclin D com- Medicine Branch [A. K., K. N., N. K. C., F. J. K., B. E. J.] and plexes (1). These complexes mediate phosphorylation of the Rb Developmental Therapeutics Program [R. K. V.], National Cancer Institute, Bethesda, Maryland 20889; Department of Medical protein and allow cell cycle progression beyond the G1-S-phase Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania checkpoint (2). Alterations of p16 have been described in a wide 19111 [J. Q. C., W-C. L., J. R. T.]; and Department of Medicine, variety of histological types of human cancers including astro- Duke University Medical Center, Durham, North Carolina 27710 cytoma, melanoma, leukemia, breast cancer, head and neck [M. J. K.] squamous cell carcinoma, malignant mesothelioma, and lung cancer. Alterations of p16 can occur through homozygous de- ABSTRACT letion, point mutation, and transcriptional suppression associ- ated with hypermethylation in cancer cell lines and primary Loss of p16 functional activity leading to disruption of tumors (reviewed in Refs. 3–5). the p16/cyclin-dependent kinase (CDK) 4:cyclin D/retino- Whereas the Rb gene is inactivated in a narrow range of blastoma pathway is the most common event in human tumor cells, the pattern of mutational inactivation of Rb is tumorigenesis, suggesting that compounds with CDK4 ki- inversely correlated with p16 alterations (6–8), suggesting that nase inhibitory activity may be useful to regulate cancer cell a single defect in the p16/CDK4:cyclin D/Rb pathway is suffi- growth. -
Cyclin E-CDK2 Is a Regulator of P27 Kip1
Downloaded from genesdev.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Cyclin E-CDK2 is a regulator of p27 Kip1 Robert J. Sheaff, 1 Mark Groudine, 1'4 Matthew Gordon, 1 James M. Roberts, 1's and Bruce E. Clurman 1-3,5 Divisions of 1Basic Sciences and 2Clinical Research, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington 98104; Departments of 3Medicine and 4Radiation Oncology, University of Washington, Seattle, Washington 98104 CDK inhibitors are thought to prevent cell proliferation by negatively regulating cyclin-CDK complexes. We propose that the opposite is also true, that cyclin-CDK complexes in mammmalian cells can promote cell cycle progression by directly down-regulating CDK inhibitors. We show that expression of cyclin E-CDK2 in murine fibroblasts causes phosphorylation of the CDK inhibitor p27 Kip1 on T187, and that cyclin E-CDK2 can directly phosphorylate p27 T187 in vitro. We further show that cyclin E-CDK2-dependent phosphorylation of p27 results in elimination of p27 from the cell, allowing cells to transit from G1 to S phase. Moreover, mutation of T187 in p27 to alanine creates a p27 protein that causes a G1 block resistant to cyclin E and whose level of expression is not modulated by cyclin E. A kinetic analysis of the interaction between p27 and cyclin E-CDK2 explains how p27 can be regulated by the same enzyme it targets for inhibition. We show that p27 interacts with cyclin E-CDK2 in at least two distinct ways: one resulting in p27 phosphorylation and release, the other in tight binding and cyclin E-CDK2 inhibition. -
Targeting Cyclin-Dependent Kinase 9 and Myeloid Cell Leukaemia 1 in MYC-Driven B-Cell Lymphoma
Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma Gareth Peter Gregory ORCID ID: 0000-0002-4170-0682 Thesis for Doctor of Philosophy September 2016 Sir Peter MacCallum Department of Oncology The University of Melbourne Doctor of Philosophy Submitted in total fulfilment of the degree of Abstract Aggressive B-cell lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma and intermediate forms. Despite high response rates to conventional immuno-chemotherapeutic approaches, an unmet need for novel therapeutic by resistance to chemotherapy and radiotherapy. The proto-oncogene MYC is strategies is required in the setting of relapsed and refractory disease, typified frequently dysregulated in the aggressive B-cell lymphomas, however, it has proven an elusive direct therapeutic target. MYC-dysregulated disease maintains a ‘transcriptionally-addicted’ state, whereby perturbation of A significant body of evidence is accumulating to suggest that RNA polymerase II activity may indirectly antagonise MYC activity. Furthermore, very recent studies implicate anti-apoptotic myeloid cell leukaemia 1 (MCL-1) as a critical survival determinant of MYC-driven lymphoma. This thesis utilises pharmacologic and genetic techniques in MYC-driven models of aggressive B-cell lymphoma to demonstrate that cyclin-dependent kinase 9 (CDK9) and MCL-1 are oncogenic dependencies of this subset of disease. The cyclin-dependent kinase inhibitor, dinaciclib, and more selective CDK9 inhibitors downregulation of MCL1 are used -
Cyclin E2, a Novel Human G1 Cyclin and Activating Partner of CDK2 and CDK3, Is Induced by Viral Oncoproteins
Oncogene (1998) 17, 2787 ± 2798 ã 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins Maimoona Zariwala1, Jidong Liu2 and Yue Xiong*,1,2,3 1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280; 2Department of Biochemistry and Biophysics; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599- 3280; 3Program in Molecular Biology and Biotechnology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280, USA G1 cyclin E controls the initiation of DNA synthesis by complexes with CDK4 or CDK6 to prevent the CDKs activating CDK2, and abnormally high levels of cyclin E from binding with and becoming activated by D-type expression have frequently been observed in human cyclins. The main function of CDK inhibitors is cancers. We have isolated a novel human cyclin, cyclin believed to couple diversi®ed growth inhibitory signals E2, that contains signi®cant homology to cyclin E. to the cell cycle clock. Cyclin E2 speci®cally interacts with CDK inhibitors of The decision to enter the replicative DNA synthesis the CIP/KIP family and activates both CDK2 and (S) phase or arrest in G1 is linked to diverse cellular CDK3. The expression of cyclin E2 mRNA oscillates processes such as signal transduction, cell differentia- periodically throughout the cell cycle, peaking at the tion, senescence, and oncogenic transformation G1/S transition, and exhibits a pattern of tissue (Hunter and Pines, 1994). -
Perspectives
CopyTight 0 1997 by the Genetics Society of America Perspectives Anecdotal, Historical And Critical Commentaries on Genetics Edited by James F. Crow and William F. Dove Chromosome Changes in Cell Differentiation Orlando J. Miller Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan 48201 N a recent “Perspectives” article, EEVA THEW the H19 gene. The maternal H19 allele is expressed, I (1995) called attention to a variety of alterations and its cis-acting, nontranslatable RNA product inhibits in chromosomes that occur regularly in differentiating the expression of the maternal alleles of the other three cells, have been known for many years, and are still genes, mash-2, Ins-2, and I@. The paternal H19 allele poorly understood. Theseincludedfacultatiue heterochro- is methylated and notexpressed, so the paternal alleles matinization, polyploidization by endoreduplication, under- of the other three genes are expressed. Imprinting of replication ofsome sequences inpolytene chromosomes, the Inns-2 and I@ genes is disrupted by maternal inheri- and gene amplijication. The related programmed DNA tance of a targeted deletion of the H19 gene and its loss phenomena called chromatin diminutionand chromo- flanking sequence, while paternal inheritance has no some eliminationalso belong tothis group of highly regu- effect, reflecting the normally silent state of the pater- lated developmental chromosomechanges. Here Ishall nal HI 9 allele (LEIGHTONet al. 1995). There is also a briefly review these changes, with particular emphasis cluster of several genes on human chromosome 15 that on thecell and molecular genetic approaches thathave are expressed exclusively on thepaternal chromosome; provided, or could provide, insights into the signaling these may play a role in thePrader-Willi syndrome. -
Endoreduplication in Drosophila Melanogaster Progeny After Exposure to Acute Γ-Irradiation
bioRxiv preprint doi: https://doi.org/10.1101/376145; this version posted July 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Endoreduplication in Drosophila melanogaster progeny after exposure to acute γ-irradiation Running head: Endoreduplication in Drosophila after γ- Keywords: giant chromosomes, polyteny degree, developmental rate, embryonic mortality, ionizing radiation. Daria A. Skorobagatko VN Karazin Kharkiv National University, Department of Genetics and Cytology, Svobody sq., 4, Kharkiv, 61022, Ukraine E-mail: [email protected] Phone: +380673007826 Alexey A. Mazilov Ph D NSC ‘Kharkiv Institute of Physics and Technology’, Department of Physics of Radiation and Multichannel Track Detectors, Academic str., 1, Kharkiv, 61108, Ukraine E-mail: [email protected] Phone: +380679950495 Volodymyr Yu. Strashnyuk Dr Sci (corresponding author) VN Karazin Kharkiv National University, Department of Genetics and Cytology, Svobody sq., 4, Kharkiv, 61022, Ukraine E-mail: [email protected] Phone: +380679478350 bioRxiv preprint doi: https://doi.org/10.1101/376145; this version posted July 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 Abstract The purpose of investigation was to study the effect of acute γ-irradiation of parent adults on the endoreduplication in Drosophila melanogaster progeny. As a material used Oregon-R strain. Virgin females and males of Drosophila adults at the age of 3 days were exposed at the doses of 8, 16 and 25 Gy. Giant chromosomes were studied at late 3rd instar larvae by cytomorphometric method.